Compounds > n-methyl-3,4-methylenedioxyamphetamine
Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Acute Hypercapnic Respiratory Failure

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Acute Hypercapnic Respiratory Failure in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldstein, LH1
Mordish, Y1
Abu-Kishak, I1
Toledano, M1
Berkovitch, M1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Acute Hypercapnic Respiratory Failure

ArticleYear
Acute paralysis following recreational MDMA (Ecstasy) use.
    Clinical toxicology (Philadelphia, Pa.), 2006, Volume: 44, Issue:3

    Topics: Acute Disease; Adolescent; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Quad

2006